• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Banook-CardiaBase Group’s subsidiaries consolidate under name of parent company

Banook-CardiaBase Group’s subsidiaries consolidate under name of parent company

May 20, 2015
CenterWatch Staff

Banook Group, an international provider of cardiac safety, central imaging and endpoint adjudication services, will combine its three subsidiaries into one unique name and brand. To accompany the rebrand, Banook Group has introduced a new logo and launched a new website, www.banookgroup.com.

The group’s subsidiaries, CardiaBase in Nancy, France, a cardiac core laboratory; Banook Central Imaging in Nancy, France, a global service organization providing medical image management for clinical research; and Banook in Mystic, Conn., the U.S. operational base, now are gathered under the Banook Group name. The three entities remain wholly owned subsidiaries. 

Using a single name reinforces the group’s strategy in centralizing its activities, expanding its line of services and strengthening its global positioning.

Banook Group now is one of the few groups able to offer a complete range of services in cardiac safety, central imaging and endpoint adjudication. Banook Group’s mission is to help its clients conduct clinical trials of the highest quality in the least amount of time, to secure regulatory approval and ultimately bring new solutions to the market for the benefit of patients worldwide.

Since its establishment in 1999, the group has achieved tremendous growth, including a 20% increase in turnover last year and diversification in its business activities. This rebrand is an important milestone for the Banook Group as it will help with the implementation of its worldwide growth strategy.

“Banook Group highly values improving the life of millions of patients throughout the world,” said Dr. Pascal Voiriot, president of Banook Group. “Banook Group represents a simple and modern update to the visual identity of the company. It is indicative of our corporate culture and commitment to connecting science and people. We never forget that behind the numbers, metrics and data flows, there are patients.”

Between 2014 and 2018, the CRO market is expected to grow at a 7.9% annual rate and reach the $32 billion mark in 2018, according to an ISR report. The central and core laboratories market (including cardiac safety and imaging assessment) represents almost 10% of this market ($3 billion a year) and is vital to the successful development of new drugs.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing